RxDoctor Payments Data

Anders Peck, MD

Rheumatology · Seattle, WANPI 1811126477

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 15th percentile of 157 rheumatology providers in Washington.

See all rheumatology providers in Washington

Medicare billing

Part B allowed, 2024
$620,753
Medicare patients
376
Services billed
33,342

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enbrel SureclickEtanercept54$467,936
Humira(Cf)Adalimumab22$370,856
Humira(Cf) PenAdalimumab22$276,522
EnbrelEtanercept28$159,797
Cosentyx Sensoready PenSecukinumab14$145,062
RinvoqUpadacitinib16$126,871
Xeljanz XrTofacitinib Citrate19$108,141
SimponiGolimumab17$102,141
TymlosAbaloparatide13$36,118
Hydroxychloroquine Sulfate252$10,193
MethotrexateMethotrexate Sodium328$9,542
Xtampza ErOxycodone Myristate11$6,630
Gabapentin159$4,076
Colchicine48$3,667
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen107$3,558

Paid to pharmacies, not to this prescriber.

Other rheumatology in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →